Dr. Kuzmich heads the firm’s Life Sciences group, focusing her practice on strategic intellectual property counseling and product life-cycle management in the areas of pharmaceuticals, chemicals, and biotechnology. Recognizing that life-cycle management is continuous and dynamic, she is skilled in developing and managing diverse patent portfolios that take into consideration a client’s immediate and long-term business objectives. She specializes in counseling clients on how to obtain intellectual property protection on pharmaceuticals and biological products in the research stage, and how to strengthen that protection throughout development, product launch, and beyond. Her extensive experience in pharmaceutical litigation allows her to offer a distinctive approach to protecting and maximizing the value of intellectual property assets. By advising on patent prosecution strategy with an eye towards litigation, Dr. Kuzmich collaborates with clients to devise strong and diverse intellectual property protection for a life science product.
Upon completion of her graduate degree in pharmacology, Dr. Kuzmich became a post-doctoral research associate with the Fox Chase Cancer Center where she investigated mechanisms of anti-cancer drug resistance. She spent several years in the private pharmaceutical sector, managing departments in the U.S. in the areas of drug metabolism and pharmacokinetics, and also collaborating with Asian and European counterparts to coordinate worldwide regulatory submissions. She earned her J.D. from Fordham Law School in 2001.
Her educational background and practical experience in the pharmaceutical sector, along with her expertise in patent procurement and defense, give Dr. Kuzmich the ability to appreciate and strategically manage the complex intellectual property issues that are critical to pharmaceutical and biotechnology clients.